Holen Sie sich die Stockscreener-App
123.02
7.67%
-10.22
Vorhandelsmarkt:
127.75
4.73
+3.84%
Spruce Biosciences Inc Aktie (SPRB) Neueste Nachrichten
Spruce Biosciences stock upgraded by Citizens on promising MPS IIIB therapy - Investing.com
Levi & Korsinsky Reminds Spruce Biosciences Investors of the Ongoing Investigation into Potential Violations of Securities LawsSPRB - ACCESS Newswire
Spruce Biosciences CFO vests 2,053 RSUs; owns 6,066 shares - Stock Titan
SPRB insider filing: CEO nets 3,245 shares after RSU vest - Stock Titan
The science behind the therapy that catapulted a biopharma’s stock 1,400% and counting - healthcare-brew.com
Leerink Partners Maintains Spruce Biosciences (SPRB) Market Perform Recommendation - Nasdaq
Spruce Biosciences (SPRB): Analyst Raises Price Target Significa - GuruFocus
Spruce Biosciences stock price target raised to $160 from $10 at Leerink - Investing.com Philippines
Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough – Inside the Stock Surge, Pipeline & Outlook (Oct 2025) - ts2.tech
Mintz Advises the Placement Agents in Spruce Biosciences, Inc.’s $50 Million Private Placement - Mintz
Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough News – Experts Weigh In - ts2.tech
Spruce Biosciences (NASDAQ:SPRB) Upgraded at Zacks Research - Defense World
SPRUCE BIOSCIENCES, INC. trading resumes - MSN
SPRB director steps down; company notes no disagreement - Stock Titan
Spruce Biosciences, Inc. Announces Resignation of Bali Muralidhar as Member of Board of Directors and as Member of the Compensation Committee of the Board, Effective October 15, 2025 - MarketScreener
Spruce Biosciences Stock More Than Quadruples After Breakthrough Therapy Designation To Therapy For Rare And Fatal Genetic Disease - MSN
Head to Head Contrast: PyroGenesis Canada (NASDAQ:PYRGF) vs. Spruce Biosciences (NASDAQ:SPRB) - Defense World
What Makes Spruce Biosciences, Inc. (SPRB) a Strong Momentum Stock: Buy Now? - sharewise.com
Spruce Biosciences’ (SPRB) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World
Spruce Biosciences insider filing shows 256-share buy, 1,050 held - Stock Titan
Spruce Biosciences to sell 502,181 shares at $68.00 in private placement - MSN
Spruce Biosciences (NASDAQ:SPRB) Shares Down 1% – What’s Next? - Defense World
Spruce Biosciences (NASDAQ:SPRB) Shares Down 1%What's Next? - MarketBeat
Medical Stocks To ConsiderOctober 6th - MarketBeat
Promising Pharmaceutical Stocks Worth WatchingOctober 6th - MarketBeat
Parkman healthcare sells Spruce Biosciences (SPRB) shares for $4920 By Investing.com - Investing.com UK
Spruce Biosciences, Inc. announced that it has received $49.999769 million in funding - MarketScreener
Parkman healthcare sells Spruce Biosciences (SPRB) shares for $4920 - Investing.com India
SPRUCE BIOSCIENCES, INC. trading halted, volatility trading pause - MSN
Spruce Biosciences announces $50M private placement financing - TipRanks
Spruce Biosciences (SPRB) Secures $50M for Therapy Advancements - GuruFocus
Three Biotech Stocks Jump After Big Regulatory Wins - Finimize
Spruce Biosciences (SPRB) Secures $50M for Enzyme Replacement Th - GuruFocus
Spruce Biosciences to Raise $50 Million Through Private Placement; Shares Down Pre-Bell - MarketScreener
Spruce Biosciences (SPRB) Secures $50 Million for Enzyme Therapy Development - GuruFocus
Spruce Biosciences secures $50 million in private placement By Investing.com - Investing.com Canada
Spruce Biosciences secures $50 million in private placement - Investing.com
Spruce Biosciences (SPRB) Secures $50M in Private Placement for Therapy Advancement - GuruFocus
Spruce Bio jumps after breakthrough therapy status for enzyme replacement therapy - MSN
Spruce Biosciences announces $50.0 million private placement financing - MarketScreener
ContactThe Lethbridge HeraldNews and Sports from around Lethbridge - FinancialContent
Small Cap Stocks To Follow Today – October 6th - Defense World
Understanding the Current Trends in SPRB Stock - Info Petite Nation
Medical Stocks To Consider – October 6th - Defense World
Biotech And Tech Stocks Rally On Breakthrough News And Partnerships - Finimize
Spruce Biosciences Stock: Emergent Surges and Market Implications - timothysykes.com
SPRB Stock Hits 19-Month High Amid Trading Halts - NewsBreak: Local News & Alerts
Spruce Biosciences’ Breakthrough: Stock Skyrockets - StocksToTrade
Spruce Biosciences Soars: What’s Driving the Surge? - timothysykes.com
Spruce Biosciences (SPRB) Stock Jumps 30% After Hours Following Red Hot Rally On Monday: Here's Why - NewsBreak: Local News & Alerts
0.00%
2.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):